Health
COVID-19 vaccine developed by German research group fails in early trial – TheChronicleHerald.ca
FRANKFURT (Reuters) – A coronavirus vaccine developed by the German Centre for Infection Research (DZIF) and vaccine maker IDT Biologika did not prompt the hoped-for…
FRANKFURT (Reuters) – A coronavirus vaccine developed by the German Centre for Infection Research (DZIF) and vaccine maker IDT Biologika did not prompt the hoped-for immune reaction in early-stage testing on humans, trial organisers at university hospital Hamburg-Eppendorf (UKE) said on Friday.
Further testing has been suspended until the cause for the weak immunogenicity in the Hamburg trial involving 30 volunteers has been established, UKE said in a statement, adding that the vaccine was well…
-
Noosa News16 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified
-
Noosa News18 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
General22 hours agoOne person dead after house fire in Melbourne’s south-east
-
General15 hours agoPostecoglou’s message touches Blues AFL coach Voss after Spurs’ Europa League win